Literature DB >> 21930499

FFR in bifurcation stenting: what have we learned?

Bon-Kwon Koo1, Bernard De Bruyne.   

Abstract

Although various angiographic or flow criteria are currently used to evaluate the severity of side branch lesions, none of these has been validated yet. Moreover, angiographic evaluation alone is sometimes inaccurate and does not reflect the functional severity of stenosis, especially in ostial lesions. Fractional flow reserve (FFR) is an easily obtainable lesion-specific parameter for the physiologic evaluation of epicardial coronary artery stenosis, which takes into account the interaction between the anatomic stenosis and the area of perfusion supplied by a specific coronary artery. Recently, a series of investigations was performed to compare the functional severity and angiographic severity in side branch lesions and to evaluate the functional outcomes of jailed side branch lesions during follow-up. From these studies, it was found that 1) FFR-guided provisional side branch intervention strategy is feasible and effective, 2) angiographic evaluation overestimates the functional severity of jailed side branch lesions in every step of the provisional strategy for bifurcation lesions and 3) functional status of jailed side branch lesions after drug-eluting stent implantation does not change significantly during follow-up.

Entities:  

Mesh:

Year:  2010        PMID: 21930499     DOI: 10.4244/EIJV6SUPJA15

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  2 in total

Review 1.  Stenting of coronary bifurcation lesions: a literature and technical review.

Authors:  Joo Myung Lee; Kyung Woo Park; Bon-Kwon Koo; Hyo-Soo Kim
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

2.  Long-term outcomes of simple crossover stenting from the left main to the left anterior descending coronary artery.

Authors:  Ho-Myung Lee; Chang-Wook Nam; Yun-Kyeong Cho; Hyuck-Jun Yoon; Hyoung-Seob Park; Hyungseop Kim; In-Sung Chung; Yun-Seok Heo; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  Korean J Intern Med       Date:  2014-08-28       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.